>CNEAMKEG_00001 30S ribosomal protein S1
MANFGAFVEIAPGVQGLVHISEIAHKHIGTPGEVLEPGQQVNVKILGIDEENERVSLSIK
ATLPNEDVVESDPSTTKAYLENEEEDNPTIGDMIGDKLKNLKL
>CNEAMKEG_00002 GTPase Der
MTKPIVAIVGRPNVGKSTIFNRIVGERVSIVEDTPGVTRDRIYSSGEWLTHDFNIIDTGG
IEIGDAPFQTQIRAQAEIAIDEADVIIFMVNVREGLTQSDEMVAQILYKSKKPVVLAVNK
VDNMEMRTDVYDFYSLGFGEPYPISGSHGLGLGDLLDAVVSHFGEEEEDPYDEDTIRLSI
IGRPNVGKSSLVNAILGEDRVIVSNVAGTTRDAIDTEYSYDGQDYVLIDTAGMRKKGKVY
ESTEKYSVLRALKAIERSNVVLVVIDAEQGIIEQDKRVAGYAHEQGKAVVIVVNKWDTVE
KDSKTMKKFEDEVRKEFQFLDYAQIAFVSAKERTRLRTLFPYINEASENHKKRVQSSTLN
EVVTDAISMNPTPTDKGRRLNVFYATQVAIEPPTFVVFVNDVELMHFSYKRYLENQIRAA
FGFEGTPIHIIARKRN
>CNEAMKEG_00003 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MTKITVFGMGSFGTALANVLAENGHDVLMWGKNQDAVDELNTCHTNKKYLKYAKLDVNII
ATSDMTKAIQFADIYLMALPTKAMREVATQINDKLTSKKTFIHVAKGIENGTFKRVSEMI
EDSISPEYNAGIGVLSGPSHAEEVVVKQPTTVAASSKDKSVSKLTQDLFMNDYLRVYTND
DLIGVELGGALKNIIAVASGIVAGIGYGDNAKAALMTRGLAEISRLGEKLGADPMTFLGL
GGIGDLIVTCTSTHSRNFTLGYKLGQGESMDQALSEMNMVVEGIYTTKSVYHLAKEKNVD
MPITNALYRVLFENISVKECVKDLMERDKKSE
>CNEAMKEG_00004 DNA-binding protein HU
MNKTDLINAVAEQADLTKKEAGSAVDAVFESIQNSLAKGEKVQLIGFGNFEVRERAARKG
RNPQTGKEIDIPASKVPAFKAGKALKDAVK
>CNEAMKEG_00005 hypothetical protein
METTVSKLERQIEERLKGVSEYESININHRLGKLLDSYDIPDVAKVACLTIDTSMRHLDD
ITYNHLSKHSILIGDLISAHFYTLLAEINDLSFQNEISKAIVEINELKSSLHHQALNDYE
ISQAIVKIETLFPYITLSHFGINIDESEIYNYLFEDMSDYYPSYFKKYNQSEVKHYLHDI
QKSYLKSRGN
>CNEAMKEG_00006 Demethylmenaquinone methyltransferase
MADNKANKEQVHRVFQNISKKYDKLNNIISFEQHKVWRKRVMKDMGVRKGTKALDVCCGT
GDWTIALSKAVGPTGEVTGIDFSENMLEVGKEKTASMENVKLVHGDAMELPFEDNSFDYV
TIGFGLRNVPDYLVALKEMNRVLKPGGMVVCLETSQPTLPVFKQMYALYFKFVMPIFGKL
FAKSKEEYEWLQQSTFNFPGKEELKRMFEEAGFINVRVRSFTGGVAAMHLGYKEKDNTKG
D
>CNEAMKEG_00007 Heptaprenyl diphosphate synthase component 2
MNNEIKKVEQRLEKAIKSKDSVLEQASLHLLSSGGKRVRPAFVILSSQFGKDEQTSEQTY
QVAVALELIHMATLVHDDVIDKSDKRRGKLTISKKWDQTTAILTGNFLLALGLEHLMAVK
DNRVHQLISESIVDVCRGELFQFQDQFNSQQTIINYLRRINRKTALLIQLSTEVGAITSQ
SDKETVRKLKMIGHYIGMSFQIIDDVLDFTSTEKKLGKPVGSDLLNGHITLPILLEMRKN
PEFKVKIEQLRRDSERKEFEECIQIIRKSDSIDEAKAVSSKYLSKALDLISELPDGHPKS
LLLSLTKKMGSRNT
>CNEAMKEG_00008 Nucleoside diphosphate kinase
MERTFLMIKPDAVQRNLIGEVISRIERKGLKLVGGKLMQVPMELAETHYGEHQGKPFYND
LISFITSAPVFAMVVEGEDAVNVSRHIIGSTNPSEASPGSIRGDLGLTVGRNIIHGSDSL
ESAEREINLWFNENEITSYASPRDAWLYE
>CNEAMKEG_00009 hypothetical protein
MKNIISIILGILMFLKSMELLYGAIFLDKPLNPITKIIFILTLIYIFYVLVKELIIFLKS
KYNESA
>CNEAMKEG_00010 Chorismate synthase
MRYLTSGESHGPQLTVIVEGIPANLEIKVEDINKEMFKRQGGYGRGRRMQIEKDTVEIVS
GVRNGYTLGSPITMVVTNDDFTHWRKIMGAAPISDEERENMKRTITKPRPGHADLVGGMK
YNHRDLRNVLERSSARETAARVAVGALCKVLLEQLDIEIYSRVVEIGGIKDKDFYDSETF
KANLDRNDVRVIDDGIAQAMRDKIDEAKNDGDSIGGVVQVVVENMPVGVGSYVHYDRKLD
GRIAQGVVSINAFKGVSFGEGFKAAEKPGSEIQDEILYNTELGYYRGSNHLGGLEGGMSN
GMPIIVNGVMKPIPTLYKPLNSVDINTKEDFKATIERSDSCAVPAASIVCEHVVAFEIAK
ALLEEFQSNHIEQLKQQIIERRQLNIEF
>CNEAMKEG_00011 3-dehydroquinate synthase
MKLQTTYPSNNYPIFVEHGAIDHISTYIDQFDQSFILIDEHVNQYFADKFNDILSFGNVH
KVIIPAGEKTKTFEQYQETLEYILSHHVTRNTAIIAVGGGATGDFAGFIAATLLRGVHFI
QVPTTILAHDSSVGGKVGINSKQGKNLIGAFYRPDAVIYDLDFLNTLPFDEILSGYAEVY
KHALLNGKSATHDIEQHFKDRASLQSLNGIDKYITKGIETKLNIVVADEKEQGVRKYLNL
GHTFGHAVEYNHKIAHGHAVMIGIIYQFIVANILFNSNHDIQHYINYLTKLGYPLETITD
IDFETIYQYMLSDKKNDKQGVQMVLIKHFGDIVVQHVDQLTLQHACEQLKTYFK
>CNEAMKEG_00012 3-phosphoshikimate 1-carboxyvinyltransferase
MVNEQIIDISGPLKGEIEVPGDKSMTHRAIMLASLAEGVSTIYKPLLGEDCRRTMDIFRL
LGVEIKEDDEKLVVTSPGYQSFNTPHQVLYTGNSGTTTRLLAGLLSGLGIESVLSGDVSI
GKRPMDRVLRPLKSMNANIEGIEDNYTPLIIKPSVIKGINYKMEVASAQVKSAILFASLF
SKEPTIIKELDVSRNHTETMFRHFNIPIEAEGLSITTTPEAIRYIKPADFHVPGDISSAA
FFIVAALITPGSDVTIHNVGINPTRSGIIDIVEKMGGNIQLFNQTTGAEPTASIRIQYTP
MLQPITIEGELVPKAIDELPVIALLCTQAVGTSTIKDAEELKVKETNRIDTTADMLNLLG
FELQPTNDGLIIHPSEFKTNATVDSLTDHRIGMMLAVASLLSSEPVKIKQFDAVNVSFPG
FLPKLKLLENEG
>CNEAMKEG_00013 Beta-barrel assembly-enhancing protease
MEDIYKLIDDINLQKLENLDSRVNEAITTDNDDALFILGETLYNFGLMPQGLEVFRVLYH
KYPDESELLIYFIEGLMSENQTDEALEYLSYVEPSPEKLMLEADLYQQINMMEVAIDKLQ
EALELEPNDPIIHFALAEMLYYDGQYLRATSEYETVLETGEYQVNGVNLFSRMADCSLQS
GNYSDAIRLYDEINEDEMTSEDYLKKAISYDKNDITQEAIKIMTTLLSKDPDYIQGYLYL
QSLYENEKNYPDAIETGKEGLRLSQFYKELMYTTGCLEIEHGDANEGVLLLKQALEVDNA
YQEPLLILSDLYRNEEDYEAIIELLTYVDEEDLDPTFMWHLAFAYGQEERDKEAQHFFEL
AYPTMKTNIDFMSDYYFYLIEIGQKEQAITILNQLLELEPSNENWHDELSRLQS
>CNEAMKEG_00014 hypothetical protein
MGYLMSETLNQIKESFIEYLLFQYRFKSRIAVWVLNYIKVNEAKLANTHFVDTKINHHET
LEIAEVGSHASAIQFTKRNIKLMNTNEIFDYIANHNCAFDIQIHFANVSKREQRLDDLIV
AQLTESPSYQTYLHDLNSMAIDRHKHALLIDYLLHNIDLSLQMNEKQRFYQLTQILNTLK
LVNKHNQFEDLADDD
>CNEAMKEG_00015 hypothetical protein
MTINTFWQYTLYQRSWLMMLLICNILGMIYGYIWYGEQLSHTPWHFKIFVPDSPTAILYL
VISISLILIQKQNSIIDALAFVTLFKYGIWAVIMNILFIIEQGDITVNGLVLMFSHSIMA
VQAIYFYPRFKRSMIGISVAMIWVFLNDYIDYFHLQFPYYDFITTHVWQIGVLSCCLSVF
GLLLYIELNKLLKCK
>CNEAMKEG_00016 hypothetical protein
MSSIFTMIIYFVILMVLPLWAQHKVKSNYEKYSQVRSTSGKTGREVALEILHANGIYDVE
VVKGEGFLTDHYDPKKKVVSLSPANYDRPSVAGTAIAAHEVGHAIQDHQGYWFLRFRAAL
VPVANLGSSLSYMIIMLGIILTAIGSAFGSTALWIGAGLMSLAVLFSIVTLPVEFDASSR
AMKQITALNIVNEKEYKHARKVLSAAAMTYVAATAVAVAELVRIILIARSSD
>CNEAMKEG_00017 putative protein YpjD
MKSMVEMQREVDEYIGQFKTGYFSPLANLARLTEEVGELAREINHTYGEKKKKDSEEANT
IKAELGDNLFVLLCLANSMGIDMTESFNETMEKFNTRDKNRFERK
>CNEAMKEG_00018 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIGITCYPSMGGSGIIATELGIKLAERGHEVHFITSNIPFRIRKPLPNMIFHQVEVNQY
AVFQYPPYDITLSTKIAEVIKEYDLDLLHMHYAVPHAICGILAREMSGKDIKIMTTLHGT
DITVLGYDHSLQGAIKFGIEKSDIVTSVSKSLAQETHEIIETNKEIIPIYNFVRENEFPT
KHNTALKSQFGIAPDEKVLIHVSNFRQVKRIDTIIETFAKVREKIPSKLILLGDGPELVP
MRQLTKELNVEEDVLFLGKQDCVSEFYQLSDLVLLLSEKESFGLTLLEAMKTGVVPIGSN
AGGIKEVIKHGETGFVVDVGDCDSASDYAIRLLEDKALYNKLQKNMLADIAERFGSELIT
DQYEYYYQKMLNEHNKSKGE
>CNEAMKEG_00019 CCA-adding enzyme
MDKSLFEQARPILEQIQDNGFEAYYVGGSVRDYVMGRNIHDIDITTSATPDEIESIFSHT
IPVGKEHGTINVVFNDENYEVTTFRAEEDYVDHRRPSGVTFVRDLYEDLQRRDFTMNAIA
MDTAYKLYDYFDGQQDINNRIIRTVGIAEERFQEDALRMIRCLRFQSQLSFDIATETFEA
MRTQMADIKFLSIERIVIELTKLMRGINVEESFNHLKSLKAFNYMPYFEHLDMNQINVTE
AIDLELLIAIASVKFDINYSLKPLKLSNRQVKDINQYIQIMNALPSIITKEQLKMFVYDY
DTNLIKNVMVAADVLKANDIQGHEPLIVNLQTIDETLHRLPMHNRKDMMVNGGVLMAHLN
AKSGPWLKDVLRQIEIAIVTGKVSNEETEILKWVDNHVKI
>CNEAMKEG_00020 Bifunctional ligase/repressor BirA
MSKYSQDVLQLLYKNKPNYISGQSIAESLNISRTAVKKVIDQLKLEGCKIDSVNHKGHLL
QQLPDIWYQGIIDQYTKSSALFDFSEVYDSIDSTQLAAKKSLVGNQSSFFILSDEQTKGR
GRFNRHWSSSKGQGLWMSVVLRPNVAFSMISKFNLFIALGIRDAIQHFSQDEVKVKWPND
IYIDNGKVCGFLTEMVANNDGIEAIICGIGINLTQQLDDFDESIRHRATSIQLNDKNKLD
RYQFLERLLQEIEKRYNQFLTLPFSEIREEYIAASNIWNRTLLFTENDKQFKGQAIDLDY
DGYLIVRDEAGESHRLISADIDF
>CNEAMKEG_00021 3'-5' exonuclease DinG
MGMATYAVVDLETTGNQLDFDDIIQIGITFVRNNQIIDTYHSMIRTNLEIPPFIQALTSI
EENMLQQAPYFNQVAQEIYDKIKDCIFVAHNVDFDLNFIKKAFKDCNIQYRPKKVIDTLE
IFKIAFPTDKSYQLSELAEAHGINLANAHRADEDAATTAKLMILAFEKFEKLPLDTLKQL
YYLSKQLKYDLYDIFFEMVRQYDAKPLDKSYEKFEQIIYRKQVDFKKPTTNYNGSLKSLY
SKAVDQLGLTYRPQQLYLAETILDQLMHSEKAMIEASLGSGKSLAYLLAALMYNIETGKH
VMISTNTKLLQSQLLEKDIPAMNEALNFKINALLIKSKSDYISLGLISQILKDDTSNYEV
NILKMQLLIWITETPSGDIQELNLKGGQKMYFDQKIETYVPARHDVHYYNFIKRNAQNIQ
IGITNHAHLIHSDVENSIYQLFDDCIVDEAHRLPDYALNQVTNELSYADIKYQLGLIGKN
ENEKLLKAIDQLEKQRILEKLDIAPIDIFGLKASMNEIHELNEQLFSTIFTIINDSDVYD
DDIHRFHNVFTFETKDILKDLHAIIDKLNKTLEIFNGISHKTVKSLRKQLLYLKDKFKNI
EQSLKAGHTSFISIKNLSQKSTIRLYVKDYAVKDVLTKQVLEKFKSLIFISGTLKFNHSF
EAFKQLFNKDVHFNTFEVNTSLQSAKNTSVFIPSDVASYQYKNIDEYVASIVSYIIEYTT
ITSSKCLVLFTSYKMMHMVQDMLNELPEFEDYVVLTQQQNQNYKIVQQFNNFDKAILLGT
STFFEGFDFQANGIKCVMIAKLPFMNKHNAKYWLMDSEFTSTFKEYVLPDAVTRFRQGLG
RLIRNENDRGIIVSFDDRLINSNYKNFFEQTLENYRQKKGDIQQFGKLLRQIQKKKK
>CNEAMKEG_00022 Asparagine--tRNA ligase
MKTTIKQAKDHLNQDVTIGAWLTNKRSSGKIAFLQLRDGTGFMQGVVVKSEVDEEVFKLA
KEITQESSLYVTGTITEDNRSDLGYEMQVKSIEVISEAHDYPITPKNHGTEFLMDHRHLW
LRSKKQHAVMKIRNEVIRATYEFFNKDGFTKVDPPILTASAPEGTSELFHTKYFDQDAFL
SQSGQLYLEAAAMAHGKVFSFGPTFRAEKSKTRRHLIEFWMIEGEMAFTNHAESLEIQEQ
YVTHVVKSVLENCKLELKMLERDTSKLEKVATPFPRISYDDAIEFLKAEGFDDIEWGEDF
GAPHETAIANHYDLPVFITNYPTKIKPFYMQPNPENEETVLCADLIAPEGYGEIIGGSER
VDDLELLEQRVKEHGLDEEAYSYYLDLRRYGSVPHCGFGLGLERTVAWISGVEHVRETAP
FPRLLNRLYP
>CNEAMKEG_00023 DNA replication protein DnaD
MDKYQLKARPVVIRRELLDHYSDLGLDEQDLVILLKLIYASETSNKQPSIELLQKGSTMQ
PRDITMVIQNLIQRELLELQVQKDEEGRFTEYMNLDPFFEKLSHILKQQSMETKEQNSKE
KFKQLFRVLEDTFARPLSPYEIETLNQWIDVDKHDTAIIQAALDEANSLNKLSFKYMDRI
LLNWKKNNVKTIDDSRKIREKFNKPKMTHTVKTVPKFDWLNGENLDGK
>CNEAMKEG_00024 Endonuclease III
MVSKKKALEMIDVIANMFPDAECELKHDNPFELTIAVLLSAQCTDVLVNRVTTELFKKYK
TPEDYLAVSDEELMNDIRSIGLYRNKAKNIKKLCQSLIDQFNGEIPQTHKELESLAGVGR
KTANVVMSVAFDEPSLAVDTHVERVSKRLGINRWKDNVRQVEDRLCSVIPRDRWNRSHHQ
LIFFGRYHCLARKPKCDICPLLEDCREGQKRYKASLKEA
>CNEAMKEG_00025 hypothetical protein
MTNITKEVFDNLEQEIDVFAKNKTLGSSEAKPYLDEYHSKIIDYFKQVNDITGNIDFDNL
NQYPVVPMNFKERYDYMIERKYHFMGYRQMKTFKTELIKMNASYQTRLKNKQV
>CNEAMKEG_00026 Penicillin-binding protein 1A/1B
MTENKGSSQPKKNGNNGGKSNSKKNRNVKRTIIKIIGFMIIAFFVVLLLGILLFAYYAWK
APAFTEAKLQDPIPAKIYDKNGELVKTLDNGQRHEHVNLKDVPKSMKDAVLATEDNRFYE
HGALDYKRLFGAIGKNLTGGFGSEGASTLTQQVVKDAFLSQHKSIGRKAQEAYLSYRLEQ
EYSKDDIFQVYLNKIYYSDGVTGIKAAAKYYFNKDLKDLNLAEEAYLAGLPQVPNNYNIY
DHPKAAEDRKNTVLYLMHYHKRITDKQWEDAKKIDLKANLVNRTAEERQNIDTNQDSEYN
SYVNFVKSELMNNKAFKDENLGNVLQSGIKIYTNMDKDVQKTLQNDVDNGSFYKNKDQQV
GATILDSKTGGLVAISGGRDFKDVVNRNQATDPHPTGSSLKPFLAYGPAIENMKWATNHA
IQDESSYQVDGSTFRNYDVKSHGTVSIYDALRQSFNIPALKAWQSVKQNAGNDAPKKFAA
KLGLNYEGDIGPSEVLGGSASEFSPTQLASAFAAIANGGTYNNAHSIQKVVTRDGETIEY
DHTSHKAMSDYTAYMLAEMLKGTFKPYGSAYGHGVSGVNMGAKTGTGTYGAETYSQYNLP
DNAAKDVWINGFTPQYTMSVWMGFSKVKQYGENSFVGHSQQEYPQFLYENVMSKISSRDG
EDFKRPSSVSGSIPSINVSGSQDNNTTNRSAHGGSDTSANSSGTAQSNNNTRSQQSRNSG
GLTGIFN
>CNEAMKEG_00027 Holliday junction resolvase RecU
MLCIINNVYYQTCVVKFMNYPNGKPYRKNSAIDGGKKTAAFSNIEYGGRGMSLEKDIEHS
NAFYLKSDIAVIHKKPTPVQIVNVNYPKRSKAVINEAYFRTPSTTDYNGVYQGYYIDFEA
KETKNKTSFPLNNIHDHQVEHMKNAYQQKGIVFLMIRFKTLDEVYLLPYSKFEIFWKRYK
DNIKKSITVDEIRKNGYHIPYQYQPRLDYLKAVDKLILDESEDRV
>CNEAMKEG_00028 hypothetical protein
MTNTVYCDKLKNVGGVLMNDVVESLIYEVNNMQQNFENVKSQQQDHDFYQTVKPYTEHID
SMLNEIKLHREFIIEVPYMNSRKFELLIANIEQLSVECHFKRTSRKLFIEKLKSVQYDLQ
NILDGVTKEGTHG
>CNEAMKEG_00029 hypothetical protein
MVKTVYVTGYKSFELNIFKDDAPEVHYLKQFIKHKIEQLLDEGLEWVLIQGQMGIELWTA
EVVIELQRTYDSLKFAVITPFQGHTEKWNEHNQSKYANIIKHADYVDSIFHTPYQGPFQF
KQADQFMLEHSDQTLLIYDEEQEASPKFFKQMLVDFMDKTNYTCDIVTFDELTAFINDLQ
WSEDQSF
>CNEAMKEG_00030 Cell cycle protein GpsB
MTYSGLKIKVSNEVEKMSDVSLKLSAKDIYEKDFEKTMARGYRREEVDAFLDDIIADYQK
MADMNNEVVKLSEENHKLKKELEELRLRVATSRPQDNKSFSSNNTTTNTSSNNVDILKRI
SNLEKAVFGK
>CNEAMKEG_00031 hypothetical protein
MLTQSEMIVVFVLDETINQGINLTAMKYPKSFDMDRVI
>CNEAMKEG_00032 Ribosomal RNA large subunit methyltransferase L
MFQLLAVCPMGLEAVVAREIQELGYETNVENGRIFFEGDASAIVKANLWLRTADRIKIVV
GRFNATTFDELFEQTKALPWESIIDKEGNFPVQGRSVKSTLHSVPDCQAITKKAIVERLR
RAYNEKGWLNESGAKYPVEVAILKDNVLLTIDTSGSGLNRRGYRLAQGEAPIKETLAASL
IRLANWKGDTPLIDPFCGSGTIAIEACLIAQNIAPGFNREFVSEQWNIMPANIYDDYRDE
ADKMADYDKEIEVYASDIDPEMVEIAKRNAEEVGLSDIIKFSVKDVNTLTIDTEEPVALI
GNPPYGERIGDREEVEEMYRYIGKLMKQHPFLSTYILTSNKEFEYLVDRKATKRRKLFNG
YIECTYYQYWGKKTERKTIEN
>CNEAMKEG_00033 hypothetical protein
MGKKMGLGLSIALVVIGIAVVCLMIFSSQKTTYFGYMNSNTNAEKVVSEKDGLVKHNIKV
EPSNDFKPKKGDFVKLVSKDGGKTFYKQEIVKHDDVPHGLMMKIHDMHMN
>CNEAMKEG_00034 hypothetical protein
MKNTFNPLQRLHFYAAIFIAPLLITLTISGIGYLFFPEVENNIYKNKFFGDSDVKTHQTL
NDAVHQVEQQYEGFFVSKVSILDEPYNKRITLSDMAGNQRYVFLDRNNQFVADQNAKHTY
SNVMRSIHSSLFTENTIINYLVELTACWTIFMILSGTYLLIKKHLISNKSKALRWQKWHA
MIGVIIAIPVFVLVITGLPWSGFMGSKIAGMMDTNGDLGQGELAINPPKSDLNELPWATR
KNKQPASSEKGSSGHHGNAAMPQTKLDYQISIDKVVEQAQKSGIKKPFSIVYPSDRNGAF
IVSNTSNSGVTGLDVSPYKEQTLYFDQYSGKKLGTIKYDDYGIIAKWFTWGIPLHEGHLF
GILNKIINLFVCIALLVAIGMGFVSWIKRTKNTAVKVPHRVKKPASISLIICLIVLGLLM
PLFGLSLILVFIIELILYIKDRRAKQ
>CNEAMKEG_00035 GTPase Der
MINKEQLDLLYKLKKEVEKSRNEALLHTINQVIKKVYLQQYTCSFVGHFSAGKSTLINLL
IEQDILPSSPVPTTSNTAIVSVSDNHDIIANLPNQTYAKLSNYDEVREMNRQNVDVESVE
INFQSTKFENGFTLQDTPGVDSNVASHQSITEQYMYTSNMIFYTVDYNHVQSELNFKFMK
HINDVGIPVVFIINQIDKHQDDELSFSTFKSRVEKSIADWGIKLERIFYVSKFDHPENEL
EVLSTYLVSLDQHRETIEDYTLRTVEYITEAQLDYIQSEIQEVLEDLGIEEAEFEQAFLN
SQQHQAISEEAQLLNNPDELMAFLKNKRKNILENAYIMPHNMREMLRSYLESMSQDFNVG
GFFNKKKKKLQIQQQRLLTATDALQEHVNQQIRQPMREDMSFVTRFINKKEASDKVLNQH
YDVKSEMIEALYQPQTSISNTYVLTFSDEVVKAIKKYVEQQSTPIFKEIIENVQADELPT
EESDDLKEYQRYTELNELRQSLTTKNYRHYYIHLDESLDKLVDRQETTYQVATDNAQGNR
DNQQLNQNTATTNMSIDIQKALDIISDVPLFKRTKQDIHETLTRIDNKLIKIGVFGTFSA
GKSSLINALLGEHILVSSPNPTTAATTEISYGDESYITLKSQSQLLDEINAVVEYQDISF
STIEDFINSDLEKLKSHLNKNQLAFVHAVEKHYKLYVSMLENGEKHAINQQELKKWSAED
EYATFVKTVHIALMHDWLKGKIIVDSLGLHSNNQRHTNETEQILTSSDLILYVSYFNHSF
TDNDKAFIEHMKDMNQLNENQAFKMVINAADLAESQDDLEAVETYVSDALRQVHLQSDIF
AVSSRNALQAEDKGIDQLKQSIQQFVDVDSKSILEQQMIHQLQQMDRSYVEMITEFETNK
ADISRRQQRLTDYKDKQRLQHQLIDATLQHTDNEVEEQVYHLNARLKLQLLDDVKSVFNS
QMTQNSDFNEEKKVSTKVYLDQIHQRLFLEQSLITERIKKYFNKQLTEQIAPIVQQLADL
HVIVNPQFNFESANIEQPLLHIDFNDMLNALPKQLTKRKILNPNGQRDIHESICQSTLGL
LQPQMGLLRQQLELYVKQMAVEAESQFESFEANIQTQINDLLAFDLDTTLINQLKDKHQQ
LKTILY
>CNEAMKEG_00036 5'-3' exonuclease
MPNKILLVDGMALLFRHFYATSLHKQFMYNSQGVPTNGIQGFVRHIFSAIHEIRPTHVAV
CWDMGQSTFRNDMFDGYKQNRSAPPEELIPQFDYVKEISEQFGFVNIGVKNYEADDVIGT
LAQQYSTDNDVYIITGDKDLLQCINDNVEVWLIKKGFNIYNRYTLHRFNEEYDLEPQQLI
DIKAFMGDTADGYAGVKGIGEKTAIKLIQQYQSVENVVENIDALSAGQRNKINDNLDELY
LSKRLAEIHTQVPIDSEALFEKMSFATTLNHILSICNEHELHVSGKYISSHF
>CNEAMKEG_00037 Alanine dehydrogenase 1
MLVAVVKELKQGEGRVACTPENVRKLTDAGHKVIVEKNAGIGSGFSDDMYEKEGAKIVTH
EQAWEADLVIKVKEPHTSEYQYFKKDQIIWGFLHLASSKEIVEKMQEVGVTAISGETIIK
NGKAELLAPMSAIAGQRSAIMGAYYSEAQHGGQGTLVTGVHENVDIPGSTYVIFGGGVAA
TNAANVALGLNAKVIIIELNDDRIKYLQDMYAEKDVTVVKSTPENLAEQIKKADVFISTI
LIPGAKPPKLVTREMVKSMKKGSVLIDIAIDQGGTIETIRPTTISDPVYEEEGVIHYGVP
NQPGAVPRTSTMALAQGNIDYILEICDKGLEQAIKDNEALSTGVNIYQGQVTNQGLATSH
DLDYKEILNVIE
>CNEAMKEG_00038 L-threonine dehydratase catabolic TdcB
MTTNTVTLQTAHIVSLGDIEEAKASIKPFIRRTPLIKSMYLSQSITKGNVFLKLENMQFT
GSFKFRGASNKINHLTDEQKEKGIIAASAGNHAQGVALTAKLLGIDATIVMPETAPQAKQ
QATKGYGAKVILKGKNFNETRLYMEELAKENGMTIVHPYDDKFVMAGQGTIGLEILDDIW
NVNTVIVPVGGGGLIAGIATALKSFNPSIHIIGVQSENVHGMAESFYKRDLTEHRVDSTI
ADGCDVKVPGEQTYEVVKHLVDEFILVTEEEIEHAMKDLMQRAKIITEGAGALPTAAILS
GKINNKWLEDKNVVALVSGGNVDLTRVSGVIEHGLNIADTSKGVVG
>CNEAMKEG_00039 Serine/threonine exchanger SteT
MSNGKELQKNIGFFSAFAIVMGTVIGSGVFFKISNVTEVTGTAGMALFVWFLGGIITICA
GLTAAELAAAIPETGGLTKYIEYTYGDFWGFLSGWAQSFIYFPANVAALSIVFATQLINL
FHLSIGSLIPIAIASALSIVLINFLGSKAGGILQSVTLVIKLIPIIVIVIFGIFQSGDIT
FSLIPTTGNSGNGFFTAIGSGLLATMFAYDGWIHVGNVAGELKNPKRDLPLAISVGIGCI
MAVYLLINATFLLTLPIELLAGNLNAASDTSKILFGENGGKIITIGILISVYGTINGYTM
TGMRVPYAMAERKLLPFSHLFAKLTKSGAPWFGAIIQLIIAIIMMSMGAFDTITNMLIFV
IWLFYCMSFVAVIILRKREPNMERPYKVPLYPIIPLIAILAGSFVLINTLFTQFILAIIG
ILITALGIPVYYYKKKQKAA
>CNEAMKEG_00040 Quinolone resistance protein NorB
MDGLLINLKFYTLKSKTIQLFYRTDKFLLWNLSVFKSIGRQIEMEKPSREAFEGNNKLLI
GIVLSVITFWLFAQSLVNVVPILEDSFNTDIGTVNIAVSITALFSGMFVVGAGGLADKYG
RIKLTNIGIILNILGSLLIIISNIPLLLILGRLIQGLSAACIMPATLSIIKSYYIGKDRQ
RALSYWSIGSWGGSGVCSFFGGAVATLLGWRWIFILSIIISLIALFLIKGTPETKSKSIS
LNKFDIKGLVLLVIMLLSLNILITKGSELGVTSLLFITLLAIAIGSFSLFIVLEKRATNP
LIDFKLFKNKAYTGATASNFLLNGVAGTLIVANTFVQRGLGYSSLQAGSLSITYLVMVLI
MIRVGEKLLQTLGCKKPMLIGTGVLIVGECLISLTFLPEILYVICCVIGYLFFGLGLGIY
ATPSTDTAIANAPLEKVGVAAGIYKMASALGGAFGVALSGAVYAIVSNMTNIYTGAMIAL
WLNAGMGILSFVIILLLVPKQNDTQL
>CNEAMKEG_00041 Extracellular matrix-binding protein ebh
MNYRDKIQKFSIRKYTVGTFSTVIATLVFLGFNTSQAHAAETNQPASVVKQKQQSNNEQT
ENRESQVQNSQNSQNGQSLSATHENEQPNINQTNHVDVSAEQSSTTENEQAVSQNKQTKK
DTADATPTQSAKAESKHEQNESRSANKKENDNKAAHVENHEANVVTASDSPDNGNVQHDR
NELQAFFDANYHDYRFIDRENADSGTFNYVKGIFDKINTLLGSNDPINNKDLQLAYKELE
QAVALIRTMPQRQQTSRRSSRIQTRSVESRAAEPRSVSSYQNADSSYYVENANDGSGYPV
GTYINASNKGAPFYLPTAPWNTLKASAAKEIVLITAKQTGDGYQWVIKFNKGHAPHENMI
FWFALPSDQVPVGRTDFVTVNADGTNVQWSNGAGAGAYKPLPQMWPYGVNDSRSRDFKIR
NRSGQVIYDWTDVHVNTLRDLARAGDYFSEAGAPAATKAIGEQTFRYINGERPTESPGAS
KVYTFIGAGDASYTISFKTQGPTTNKLYYAAGGRALEYNQLFMYSQLYVESTQDHQQRLD
GFRQVVNRSYRLDTTKRVEVSQGNIQTKKVLESTNLNIDDFMDDPLSYVKTPSNKVLGFY
PTNANPNAYRHGGTNPLNEYQLSQLFTDDKLQQAARTGNPIRLMIGFDYPDGHGNAETLV
PVNLTVLPEIQHNIKFYKNDDTQNIADKPASRQAGHPIFYVYAGNQGNASVNLGGSVTSI
QPLRINLTSSENFTDRDWQITGIPRTLHIENSTNRPNNARERNIELVGNLLPGDYFGTIR
FGRKEQLFEIRVKPHTPTITTTAEQLRGTALQKVPITVTNIPLDPSSLVYIVYPTDQTRD
GGSEADQMPSNYSILATGTPDGVHNTITIQPKDYTVFIPPVGKQIRALIYYNKVVASNMS
NAVTILPDDIPPTINNPVGLNAKYYRGDEVNFTMGVSDRHSGIKNTTITTLPNGWTSNLT
KADKNNGSLSITGRVSMNQAFNSDITFKVSATDNVNNTTNDSQSKHVTVHVGKISEDAHP
IVLANSEKVVVVNPTSVSNDEKQRIITAFMNKNQNIRGYLASSNPVTVDNNGNVTLHYRD
GSSTTLDATNVMTYEPVVKPEYQTANAPKTATVTIAKGQSFSIGDIKQYFTLSNGQAIPN
GTFTNITSDRTIPTAQEVSQMNAGTQLYHIVASNAYHKDTEDLYISLKIIDVKQPEGDQR
VYRTSTYDLTTDEISKVKQAFINANRDAITFAEGDISVTNTPNGANVSTVTVNINKGRLT
KSFTSNLANMNFLRWVNFPQDYTVSWTNAKIASRPTDGGLSWSDDHKSLIYRYDATLGTP
ITTNDILTMLKATTTVPGLRNNIAGNEKTQAEAGGRPNYRPTGYSQANASSDGQRQYTLN
GQVIQVLDIINPTNGFGGQTITNSNVRANHSNSTVVSVNEPAANGAGAFTIDHVVKNNTT
HNAADAVYKAQLYLSPYGPKQYVEHLNQNTGNTTDAINIYFVPSDLVNPTISVGNYANHQ
VFSGETFTNTITANDNFGVQSVTVPNTSQITGTVDNNHQHVSATAPNVTSATNKTINLVA
TDTSGNTATTSYNVTIKPLRDKYRVGTSSTAANPVRIANISNNAIVSQADQTAIINSLTF
TETVPNRSYARASANEITSKTVSNVSRTGNNANVTVTVTYQDGTTSTVTVPVKHVIPEIV
AHSHYTVQGQDFPAGNGSSASDYFKLSNGSAIPDATITWVSGQAPNKDNTRIGEDITVTA
HILIDGETTPITKTATYKVVRTVPKHVFETDRGVLYPGVSDMYDAKQYVKPVNNSWSTNA
QNMNFQFVGTYGPNKDVVGISTRLIRITYDNRQTEELTILSKVKPDPPRIDGNSVTYKAG
LTNQEVKVNNVLSNSTVKLFKADNTPLNVTNIIHGSGYSSVVTVSDALPNGGIKAKSSIS
MNNVTYTTQDEHGQVVTVTRNESVDSNDSASVTVTPQLQATTEGAVFIKGGDGFDFGHVE
RFIQNPPHGATVAWHDNPDTWKNTVGNTHKTAVVTLPSGQGTRNVEVPVKVYPVANAKAL
SRDVKGQNLTNGTDAMSYITFDPNTNTNGITAAWANRQQPNNQQAGVQHLNVDVTYPGIS
AAKRVPVTVNVYQFEFPQTTYTTTVGGTLASGTQASGYAHMQNATGLPTDGFTYKWNNAA
TGTNDANWAAMNKPNAAKVVNAKYDVIYNGHTFATSLPAKFVVKDVQPAKPTVTETAAGA
ITIAPGANQTVNTHAGNVTTYADKLVIKRNGSVVTTFTRHNNTSPWVKEASATNVTGIVG
TNNGITVAAGTFNPADTIQFVATQGSGETISDEQRSDDFTVVAPQPNQATTKIWQNGHID
ITPNNPSGHLINPTQAMDIAYTEKVGNGAEHSKTINVVRGQNNQWTIANKPDYVTLDAQT
GKVTFNANTIKPNSAITITPKAGTGHSASSNPSTLTAPAAHTVNTTEIVKDYGSNVTASE
INNAVQVANKRTATIKNGTAMPTNLAGGSTTTIPVTVTYNDGSTEEVQESIFTKADKREL
ITAKNHLDDPVSTDGKKPGTITQYNNAMHNAQQQINAAKTEAQQVINNERATPQQVNAAL
SKVQAAQTKINEAKALLQNKEDNSQLVTSKNNLQSSVNQVPSTAGMTQQSIDNYNAKKRE
AESEITAAQRIIDNGDATAQQISDEKHRVDNALTALNQAKHDLTADTHALEQAVQQLNRT
GTTTGKKPASITAYNNSIRALQSDLTSAKNSANAIIQKPIRTVQEVQSALTNVNRVNERL
TQAINQLVPLADNSTLRTAKTKLDEEINKSVTTDGMTQSSIQAYENAKRAGQTESTNAQN
VINNGDATDQQIAAEKAKVEEKYNSLKQAIAGLTPDLAPLQTAKTQLQNDIDQPTSTTGM
TSASVATFNEKLSAARTKIQEINRVLASHPDVATIRQNVTAANAAKSALDQARNGLTVDK
APLENAKNQLQHSIDTQTSTTGMTQDSINAYNAKLTAARNKIQQINQVLAGSPTVDQINT
NTSAANQAKSDLDHARQALTPDKTPLQNAKTQLEQSINQPTDTTGMTTASLNAYNQKLQA
ARQKLTEINQVLNGNPTVQNINDKVAEANQAKDQLNTARQGLTLDRQPALTTLHGASNLN
QAQQNNFTQQINAAQNHAALETIKSNITALNTAMTKLKESVADNNSIKSGQNYTDATQAN
KQAYDNAVNAAKGVIGETNNPTMDVNTVNQKAASVKSTKDALDGQQNLQRAKTEATNAIT
HASDLNQAQKNALTQQVNSAQNVQAVNNIKQTTQSLNTAMTGLKRGVANHNQVVQSDNYV
NADTNKKNDYNNAYNHANDIINGNPQHPVITPSDVNNALSNVTSKEHALNGEAKLNTAKQ
EANTALGQLNNLNNAQRQNLQSQINGAHQIETVNTIKQNATNLNSAMGNLRHAVADKEQV
KRTEDYADADTAKQNAYNSAVSSAETIINQSTNPTMSVDDVNRATSAVTTNKTALNGDEK
LAQSKTDAARAIDALPHLNNAQKADVKSKINAASNIAGVNTVKQQGTDLNTAMGNLQGAI
NDEQTTLNSQNYQDATPSKKTAYTNAVQAAKDILNKSNGQNKTKDQVTEAMNQVNSAKNN
LDGTRLLDQAKQTAKQQLNNMTHLTTAQKTNLTNQINSGTTVAGVHTVQSNANTLDQAMN
TLRQSIANKDATKASEDYVDANNDKQTAYNNAVAAAETIINANSNPEMNPSTITQKAEQV
NSSKTALNGDENLATAKQNAKTYLNTLTSITDAQKNNLISQISSATRVSGVDTVKQNAQH
LDQAMASLQNGINNESQVKSSEKYRDADTNKQQEYDNAITAAKAILNKSTGPNTAQNAVE
AALQRVNTAKDALNGDAKLIAAQNAAKQHLGTLTHITTAQRNDLTNQISQATNLAGVESV
KQSANSLDGAMGNLQTAINDKSGTLASQNFLDADEQKRNAYNQAVSNAETILNKQTGPNT
AKTAVEQALNNVNSAKHALNGTQNLNNAKQAAITAINGASDLNQKQKDVLKAQANGAQRV
SNAQDVQRNATELNTAMGTLKHAIADKTNTLASSKYVNADSTKQNAYTTKVTNAEHIISG
TPTVVTTPSEVTAAANQVNSAKQELNGDERLRVAKQNANTAIDALTQLNTPQKAKLKEQV
GQANRLEDVQTVQTNGQSLNNAMKGLRDSIANETTVKASQNYTDASPNNQSTYNSAVSNA
KGIINQTNNPTMDTSAITQATTQVNNAKNGLNGAENLRNAQNTAKQNLNTLSHLTNNQKS
AISSQIDRAGHVSEVTAAKNAATELNTQMGNLEQAIHDQNTVKQSVNFTDADKAKRDAYT
NAVSRAETILNKTQGANTSKQDVEAAIQSVTSAKNALNGDQNVTNAKNTAKHALNNLTSI
NNAQKRNLTTKIDQATTVAGVEAVSNTGTQLNTAMANLQNGINDKTNTLASENYHDADSD
KKTAYTQAVTNAENILNKNSGSNLDKVAVENALSQVTNAKGALNGNHNLEQAKSNANTTI
NGLQHLTTAQKDKLKQQVQQAQNVAGVDTVKSSANTLNGAMGTLRNSIQDNTGTKNGQNY
LDATESNKTNYNNAVDRANGVINATSNPNMDANAINQIATQVTSTKNALDGTHNLTQAKQ
TATNAIDGATNLNKAQKDALKAQVTSAQRVANVTSIQQTANELNTAMGQLQHGIDDENAT
KQTQKYRDAEQNKKTAYDQAVAAAKAILNKQTGSNSDKAAVDHALQQVTSTKDALNGDAK
LAEAKAAAKQNLGTLNHITNAQRTALEGQINQATTVDGVNTVKTNANTLDGAMNSLQGSI
NDKDATLRNQNYLDADESKRNAYTQAVTAAEGILNKQTGGNTSKADVDNALNAVTRAKAA
LNGADNLRNAKTSATNTINGLPHLTQLQKDNLKHQVEQAQNVAGVNGVKDKGNTLNTAMG
ALRTSIQNDNTTKTSQNYLDASDSNKNNYNTAVNNANGVINATNNPNMDANAINGMANQV
NTTKAALNGAQNLAQAKTNATNTINNAHDLNQKQKDALKTQVNNAQRVSDANNVQRTATE
LNSAMTALKAAIADKERTKASGNYVNADQEKRQAYDSKVTNAENIISGTPNATLTVNDVN
SAASQVNAAKTALNGDNNLRVAKEHANNTIDGLAQLNNAQKAKLKEQVQSATTLDGVQTV
KNSSQTLNTAMKGLRDSIANEATIKAGQNYTDASPNNRNEYDSAVTAAKAIINQTSNPTM
EPNTITQATSQVTTKEHALNGAQNLAQAKTTAKNNLNNLTSINNAQKDALTRSIDGATTV
AGVNQETAKATELNNAMHSLQNGINDETQTKQTQKYLDAEPSKKSAYDQAVNAAKAILTK
ASGQNVDKAAVEQALQNVNSTKTALNGDAKLNEAKAAAKQTLGTLTHINNAQRTALDNEI
TQATNVEGVNTVKAKAQQLDGAMGQLETSIRDKDTTLQSQNYQDADDAKRTAYSQAVNAA
ATILNKTAGGNTPKADVERAMQAVTQANTALNGIQNLERAKQAANTAITNASDLNTKQKE
ALKAQVTSAGRVSAANGVEHTATELNTAMTALKRAIADKAETKASGNYVNVDANKRQAYD
EKVTAAENIVSGTPTPTLTPSDVTNAATQVTNAKTQLNGNHNLEVAKQNANTAIDGLTSL
NGPQKAKLKEQVGQATTLPNVQTVRDNAQTLNTAMKGLRESIANEATIKADQNYTDASQS
KQTDYNNAVTAAKAIIGQTTSPTMNAQEINQAKDQVTAKQQALNGQENLRTAQTNAKQHL
NGLSDLTNAQKEAAKRQIEGATHVNEVTQAQNNADALNTAMTNLKNGIQDQNTIKRGVNF
TDADEAKRNAYTNAVTQAEQILNKAQGPNTAKDGVETALQNVQRAKNDLNGNQNVANAKT
TAKNALNNLTSINNAQKEALKSQIEGATTVAGVNQVSTTASELNTAMSNLQRGINDEAAT
KAAQKYTDADREKQTAYNDAVTAAKTLLNKTAGSNDNKAAVEQALQRVNTAKNALNGDAR
LNEAKKTAKQQLATMSHLTDAQKANLTSQIERGTTVAGVQGIQANAGTLNQAMNQLRQSI
ASKDATKSSEDYQDANTDLQNAYNRAVSDAEGIISATNNPEMNPDTINQKASQVNSAKSA
LNGDEKLAAAKQTAKTDIGRLTDLNNAQRTAANAEVDQAPNLAAVTAAKNKATSLNTAMG
NLKHALAEKDNTKRSVNYTDADRPKQQAYDTAVTQAEAITNANGSNANETQVQAALNQLN
QAKNDLNGDNKVAQAKEAAKRALASYNNLNNAQSIAATSQIDNATTVAGVTAAQNTANEL
NTAMGQLQNSINDQNTVKQQVNFTDADQGKKDAYTNAVTNAQGILDKAHGQNMTKAQVEA
ALNQVTTAKNALNGDANVRQAKSDAKANLGTLTHLNNAQKQDLTSQIEGATTVNGVNGVK
TKAQDLDGAMQRLESAIANKDQTRASENYIDADPTKKTAFDNAITQAESYLNKDHGANKD
KQAVEQAIQSVTTAKNALNGDANLQRAKTEATQAIDNLTHLNTPQKTALKQQVNAAQRVS
GVTDLKNSATSLNNAMDQLKQAIADHDTIVAGGNYTNASPDKQGAYTDAYNAAKNIVNGS
PNVVTNAADVTAATQRVNNAETGLNGDSNLATAKQQAKDALRQMTHLSAAQKQSITGQID
SATQVTGVQSVKDNATNLDNAMNQLRNSIANKDEVKASQPYVDADTDKQNAYNTAVTSAE
NIINATSQPTLDPSAVTQAANQVNTNKTALNGVQNLANKKQETTANINQLSHLNNAQKQD
LNTQVTNAPNISTVNQVKTKAEQLDQAMERLINGIQDKDQVKQSVNFTDADPEKQTAYNN
AVTAAENIINQANGTNANQSQVEAALSTVTTTKQALNGNRKVTDAKNNANQTLSTLDNLN
NAQKGAVTGNINQAHTVAEVTQAIQTAQELNTAMGNLKNSLNDKDTTLGSQNFADADPEK
KNAYNEAVHNAENILNKSTGTNVPKDQVEAAMNQVNTTKAALNGTQNLEKAKQHANTAID
GLSHLTNAQKDALKQLVQQSTTVAEAQGNEQKANNVDAAMDKLRQSIADNATTKQNQNYT
DASPNKKDAYNNAVTTAQGIIDQTTSPTLDPTVINQAAGQVSTTKNALNGNENLEAAKQQ
ATQSLGSLDNLNNAQKQTVTDQINGAHTVDEANQIKQNAQNLNTAMGNLKQAIADKDATK
ATVNFTDADQAKQQAYNTAVTNAENIISKANGGNATQTEVEQAIQQVNAAKQALNGNANV
QHAKDEATALINSSNDLNQAQKDALKQQVQNATTVAGVNNVKQTAQELNNAMTQLKQGIA
DKEQTKADGNFVNADPDKQNAYNQAVAKAEALISGTPDVVVTPSEITAALNKVTQAKNDL
NGNTNLATAKQNVQQAIDQLPNLNQAQRDEYNKQITQATLVPNVNAIQQAATTLNDAMTQ
LKQGIANKAQIKGSENYHDADTDKQTAYDNAVTKAEELLKQTTNPTMDPNTIQQALTKVN
DTNQALNGNQKLADAKQAAKTNLGTLDHLNDAQKQALTTQVEQAPDIATVNNVKQNAQNL
NNAMTNLNNALQDKTETLNSINFTDADQAKKDAYTNAVAHAEGILSKANGSNASQTEVEQ
AIQRVNEAKQALNGNDNVQRAKDAAKQVITNANDLNQAQKDALKQQVDAAQTVANVNTIK
QTAQDLNQAMTQLKQGIADKDQTKANGNFVNADTDKQNAYNNAVAHAEQIISGTPNANVD
PQQVAQALQQVTQAKGDLNGNHNLQVAKDNANTAIDQLPNLNQPQKTALKDQVSHAELVT
GVNAIKQNADALNNAMGTLKQQIQANSQVPQSVDFTQADQDKQQAYNNAANQAQQIANGT
PTPVLSPDTVTQAVTTMNQAKDALNGDEKLAQAKQDALANLDTLRDLNQPQRDALRNQIN
QAQALATVEQTKQNAQNVNATMGNLKQGIANKDTVKASENYHDADADKQTAYTNAVSQAE
GIINQTTNPTLNPDEITRALTQVTDAKNGLNGEAKLATEKQNAKDAVSGMTHLNDAQKQA
LKGQIDQSPEIATVNQVKQTATSLDHAMDQLSQAINDKAQTLADGNYLNADPDKQNAYKQ
AVAKAEALLNKQSGTNEVQAQVESITNEVKTAKQALNGNDNLANAKQQAKQQLANLTHLN
DAQKQSFENQITQAPLVTDVTTINQKAQTLDHAMELLRNSIADNQATLASEDYHDATAQR
QNDYNQAVTAANNIINQTTSPTMNPDDVNRATTQVNNTKVALDGDENLVAAKQQANNRLD
QLDHLNNAQKQQLQSQITQSSDIAAVNGHKQTAESLNTAMGNLINAIADHQAVEQRGNFI
NADTDKQTAYTTAVNEAEAMINKQTGQNANQTEVEQAITKVQTTLQALNGDHNLQVAKTN
ATQAIDALTSLNDPQKTALKDQVTAATLVTAVHQIEQTANTLNQAMHGLRESIQDNATTQ
ANSKYINEDQPEQQNYDQAVQAANNIINEQTATLDNNAINQAATTVNTTKAALHGDVKLQ
NDKDRAKQTVSQLAHLNNAQKHMEDTLIDSETTRTAVNHDLTEAQALDQLMDTLQQSIAD
KDATRASSAYVNAEPNKKQAYDEAVQNAESIIAGLTNPTINKGNVSSATQAVTSSKNALD
GVERLAQDKQTAGNSLNHLDQLTPAQQQALENQINNATTRDKVAEIIAQAQALNEAMKAL
KESIKDQPQTEASSKFINEDQAQKDAYTQAVQHAKDLINKTTDPTLAKSIIDQATQAVTD
AKNNLHGDQKLAQDKQRATETLNNLSNLNTPQRQALENQINNAATRDEVAQKLTEAQALN
QAMEALRNSIQDQQQTEAGSKFINEDKPQKDAYQAAVQHAKDLINQTSNPTLDKAQVEQL
TQAVNQAKDNLHGDQKLADDKQHAVTDLNQLNGLNNPQRQALESQINNAATRGEVAQKLT
EAQALNQAMEALRNSIQDQQQTESGSKFINEDKPQKDAYQAAVQNAKDLINQTGNPTLDK
SQVEQLTQAVTTAKDNLHGDQKLARDQQQAVTTVNALPNLNHAQQQALTDAINAAPTRTE
VAQHVQTATELDHAMETLKNKVDQVKTDKAQPNYTEASTDKKEAVDQALQAAQSITEPNN
GSNANKDAVEQALTKLQEKENELNGNERVAEAKTQAKQTVDQLTHLNADQIATAKQNIDQ
AMKLQPIA
>CNEAMKEG_00042 Extracellular matrix-binding protein EbhA
MDQLQQAVNDHTNVEQTVDYTQADSDKQNAYKQAIADAENVLKQNANKEQVDQALQNILN
AKQALNGDERVALAKTNGKHDIDQLNTLNNAQQDGFKGRIDQSNDLNEIKQIVDEAKALN
RAMNQLSQEITGNEGRTKGSTNYVNADTQVKRVYDDAVDKAKEALNKATGQNLTAEEVIK
LNDAVTAAKQALNGEERLNKRKSEALQRLDQLTHLNNAQRQLATQQINNAETLNKASRAI
NRAVQLDDAMGAVQQYIDDHHFDVISSTNYINADDNLKANYDNAITNAAHELDKVQGSAI
TKAEAEQLKQNIIDAQQALNGDQNLATAKDKANAFVDTLNGLNQQQQDLAHQAINNADTV
TGIANIINDQIDLNNAMETLKHLVDNEIPTAEQTINYQNADDVAKSIFDDAKRLANTLLN
SDNTNVNDINGAIQAVNDAIQNLNGDQRLQEAKDKAIQNVNKVLADKLKEIEASNATDQD
KLIAKNKAEELANSIINNINKATSNQDVSQVQTAGNHAIEQVHANEIPKAKIDANKDADK
QVQALIDEIDRNPNLTDKEKQALKDRINQILQQGHNGINNAMTKEEIEQAKAQLAQALQE
IKDLVKAKENAKQDVDKQVQALIDEIDRNPNLTDKEKQALKDRINQILQQGHNGINNAMT
KEEIEQAKAQLAQALQEIKDLVKAKENAKQDVDKQVQALIDEIDRNPNLTDKEKQALKDR
INQILQQGHNGINNAMTKEEIEQAKAQLAQALQEIKDLVKAKENAKNAIKALANAKRDQI
NSNPDLTPEQKAKALKEIDEAEKRALENIENAQTKDQLNQGLNLGLDDIRNTHVWEVDTQ
PAVNEIFDATPEQILVNGELIVHRDDIITEQDILAHINLVDQLTAEVIDTPSTATISDSL
TAKVEVTLLDGSKVIVNVPVKVVEKELAVVKQQAIESIENAAQQKINDINNHATLTPEQK
EAAIAEVNKLKQQAIEQINNATDVHSVEEVQQQEQTHIEQFNPEQFTIDQAKSNAIKSIT
DAIQHMIDEINASKDLTDKEKQEAISKLNQLKEQAIQAIQRAQSIDEITQQLEQFKAQIK
AANPFAKELEKRKKVAISKIKDISTDAIERIKNSSTGTAEERQAAMNRINEIVLETIRDI
NNAQTPQQVEAALNNGIARILAVQIVTSNNSKHSSDSDGESNSHISIGYGTVNHPFNSSA
IGHKKKLDQDDEIDPLHMRHFGDRIGNVIKNALGVVGISGLLASFWFFIAKRRRKEDEEE
ELEIRDNSKDKKKGSIEGTKHLPLLLAKRRRKEDEEDAIVEEKDSLNNNESLDKVKHTPF
FLPKRRRKEDEEDVEVTNENTDEKVLQDNEHSPLLIAKRRKDKEVDVETTPSIESNEDDA
PLLLAKKKNQKDNQSKGKKSASKKPSKKLVAKKKKKKSKKNKK
>CNEAMKEG_00043 14.7 kDa ribonuclease H-like protein
MAKINFDAATKGNPGISTCAVVIKEDDQHYTYTHELGEMDNHTAEWAACIYALKHARELN
VSNALLYTDSKLIADSVNAGYVKNAKFKPYFDQLEIFEQDFDLLFVKWIPREQNKEANQN
AQQALYKLIKKNK
>CNEAMKEG_00044 queuosine precursor transporter
MYNEILGLVTFIATFVLMVLMYRFFGKQGLIAWVAIGTIIANIQVIKTVEIFGISATLGN
VMFASIYLATDILNDIYGRRVAKRAVWLGFSSTLIMIIVMQLSLHFIPAPEDMAQKALHA
IFDVVPRIALGSIVAYIIGQHIDVFIFSLIKKVFSSDKTFFIRAYGSTFLSSIIDTALFV
AIAFIGSLPGTVVFEIFITTYVLKLASTVFNVPFGYIAKSFYRKGKIDKLDQGY
>CNEAMKEG_00045 hypothetical protein
MQIISISETPNHNTMKITLSESREGMTSDTYTKVDDSQPAFINDILKVEGVKSIFHVMDF
ISVDKENDANWETVLPKVEAVFE
>CNEAMKEG_00046 hypothetical protein
MEILRIEPTPSPNTMKVVLSYTREDKLSNTYKKVEENQPRFINQLLSIDGITSIFHVMNF
LAVDKAPKADWEVILPDIKAAFSGESQVLESGKDPQIDKHFGEIKAELLTFKGIPYQIKL
TSADQELREQLPQTYVDHMTQAQTEHDNIVFMRKWLDLGNRYGNIEEVMDGVLEEVLATY
PESQLPVLVKHALEENHAANNYHFYRHVSLDEYHATDNWKTRLRMLNHFPKPTFEDIPLL
DLALSDEKVPVRRQAIVLLGMIESKEILPYLYKGLRDKSPAVRRTAGDCISDLGYPEALP
EMVLLLDDSQKIVRWRAAMFIFDEGNAEQLPALKAHINDNAFEVKLQIEMAISRIENGDE
ALGSVWKQMANRTI
>CNEAMKEG_00047 hypothetical protein
MNAYDAYMKEIAQQMRGELTQNGFTSLETSEAVLEYMNQVNADDTTFVVINSTCGCAAGL
ARPAAVAVATQNEHRPTNTVTVFAGQDKEATATMREFIQQVPSSPSYALFKGQDLVYFMP
REFIEGRDINDIAMDLKDAFDENCK
>CNEAMKEG_00048 Thymidylate synthase
MLNSFDAAYHSLCEEVLEIGNTRNDRTNTGTISKFGHQLRFDLSKGFPLLTTKKVSFKLV
ATELLWFIKGDTNIQYLLKYNNNIWNEWAFENYIKSDEYKGPDMTDFGHRALSDPEFNEQ
YKEQMKQFKQRILEDDTFAKQFGDLGNVYGKQWRDWVDKDGNHFDQLKTVIEQIKHNPDS
RRHIVSAWNPTEIDTMALPPCHTMFQFYVQDGKLSCQLYQRSADIFLGVPYNIASYALLT
HLIAKECGLEVGEFVHTFGDAHIYSNHIDAIQTQLARESFNPPTLKINSDKSIFDINYED
LEIVDYESHPAIKAPIAV
>CNEAMKEG_00049 Dihydrofolate reductase
MTLSILVAHDLQRVIGFENQLPWHLPNDLKHVKKLSTGHTLVMGRKTFESIGKPLPNRRN
VVLTSDTSFNVEGVDVIHSIEDIYQLPGHVFIFGGQTLFEEMIDKVDDMYITVIEGKFRG
DTFFPPYTFEDWEVTSSVEGKLDEKNTIPHTFLHLIRKK
>CNEAMKEG_00050 DegV domain-containing protein
MTKQIIVTDSTSDLSKEYLEANNIHVIPLSLTIEGVSYVDQVDITSEEFINHIENDEDVK
TSQPAIGEFISAYEELGKDGSEIISIHLSSGLSGTYNTAYQASQMVDANVTVIDSKSISF
GLGYQIQHLVELVKEGVSTSEIVKKLNHLRENIKLFVVIGQLNQLIKGGRISKTKGLIGN
LMKIKPIGTLDDGRLELVHNARTQNSSIQYLKKEIAEFIGDHEIKSVGVTHANVIEYVDK
LKKVFNEAFHVNNYDINVTTPVISAHTGQGAIGLVVLKK
>CNEAMKEG_00051 Peptide methionine sulfoxide reductase MsrA 2
MTKEYATLAGGCFWCMVKPFTSYPGIKSVVSGYSGGHVDNPTYEQVCTNQTGHVEAVQIT
FDPEVTSFENILDIYFKTFDPTDDQGQFFDRGESYQPVIFYHDEHQKKAAEFKKQQLNEQ
GIFKKPVITPIKPYKNFYPAEDYHQDYYKKNPVHYYQYQRGSGRKAFIESHWGNQNA
>CNEAMKEG_00052 Peptide methionine sulfoxide reductase MsrB
MLKKDKSELTDIEYIVTQENGTEPPFMNEYWNHFAKGIYVDKISGKPLFTSEEKFHSECG
WPSFSKALDDDEIIELVDKSFGMVRTEVRSEESNSHLGHVFNDGPKESGGLRYCINSAAI
QFIPYEKLEELGYGDLISHFDK
>CNEAMKEG_00053 PTS system glucose-specific EIIA component
MFKKLFGKGKEVQKDIAIYAPLTGEYVKIEDIPDPVFAQKMMGEGFGINPTEGEVVSPIA
GRVDNVFPTKHAIGLKADNGLELLVHIGLDTVQLDGEGFEVLVSSGDEVNVGDPLVRFNL
EFINNNAKSVISPIIITNTDQAASINIYDENAVIKGETKVIDVTMN
>CNEAMKEG_00054 hypothetical protein
MKNYSFYQFVMTVRGRHDDKGRLAEEIFDDLAFPKHDDDFNILSDYIETHGDFTLPMSVF
DDLYEEYTEWLKF
>CNEAMKEG_00055 putative CtpA-like serine protease
MDDKQHTSSSDDERAEIATSNQDQQTNSSKRVHLKRWQFISILIGTILITAVITVVAYIF
INQKISGLNKTDQANLNKIENVYKILNSDYYKKQDSDKLSKAAIDGMVKELKDPYSEYLT
KEQTKSFNEGVSGDFVGIGAEMQKKNDQIMVTSPMKGSPAERAGIRPKDVITKVNGKSIK
GKALDEVVKDVRGKENTEVTLTVQRGSEEKDVKIKREKIHVKSVEYKKKDKVGVITINKF
QNDTSGELKDAVLKAHKDGLKKIVLDLRNNPGGLLDEAVKMANIFIDKGKTVVKLEKGKD
TEAIQTSNDSLKEAKDMDISILVNEGSASASEVFTGALKDYNKAKVYGSKTFGKGVVQTT
REFKDGSLLKYTEMKWLTPDGHYIHGKGIKPDVTIDTPKYQSLNVIPNTKTFKVGDDDKN
IKTIKIGLSALGYKVDNESTQFDQALENQVKAFQQTNKLEVTGEFNKETNNKFTELLVEK
ANKHDDVLDKLINILK
>CNEAMKEG_00056 hypothetical protein
MIRLGKMSDLDQILNLVEEAKELMKEHDNEQWDDQYPLLEHFEEDIAKDYLYVLEENNKI
YGFIVVDQDQAEWYDDIDWPVNREGAFVIHRLTGSKEYKGAATELFNYVIDVVKARGAEV
ILTDTFALNKPAQGLFAKFGFHKVGEQLMEYPPYDKGEPFYAYYKNLKE
>CNEAMKEG_00057 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKKIAFTGGGTVGHVSVNLSLIPTALSQGYEALYIGSKNGIEREMIESQLPEIKYYPISS
GKLRRYISLENAKDVFKVLKGILDARKVLKKEKPDLLFSKGGFVSVPVVIAAKSLNIPTI
IHESDLTPGLANKIALKFAKKIYTTFEETLNYLPKEKADFIGATIREDLKNGNAHNGYQL
TGFNENKKVLLVMGGSLGSKKLNSIIRENLDALLQQYQVIHLTGKGLKDAQVKKSGYIQY
EFVKEELTDLLAITDTVISRAGSNAIYEFLTLRIPMLLVPLGLDQSRGDQIDNANHFADK
GYAKAIDEEQLTAQILLQELNEMEQERTRIINNMKSYEQSYTKEALFDKMIKDALN
>CNEAMKEG_00058 hypothetical protein
MSQWKRISLLIVFTLVFGIIAFFHESRLGKWIDNEVYEFIYSSESFITTSIMLGATKVGE
VWAMLCISLLLVAYLMLKRHKIEALFFALTMALSGILNPVLKNIFDRERPTLLRLIDITG
FSFPSGHAMGSTAYFGSGIYLLKRLNQGNSKGILIGLCAAMILLISISRVYLGVHYPTDI
IAGIIGGVFCIILSTLLLRNKLIN
>CNEAMKEG_00059 hypothetical protein
MTNPTRTKRCGGDVLCGIDNHFQLLLYISENHCQLETKTFFEYFLRIVNKTHDYAILENK
KICISH
>CNEAMKEG_00060 Response regulator ArlR
MTQILIVEDEQNLARFLELELTHENYNVDTEYDGQDGLDKALSHYYDLIILDLMLPSING
LEICRKIRQQQSTPIIIITAKSDTYDKVAGLDYGADDYIVKPFDIEELLARIRAILRRQP
QKDIIDVNGITIDKNAFKVTVNGAEIELTKTEYDLLYLLAENKNHVMQREQILNHVWGYN
SEVETNVVDVYIRYLRNKLKPYDRDKMIETVRGVGYVIR
>CNEAMKEG_00061 Signal transduction histidine-protein kinase ArlS
MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKT
VKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGI
EYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQI
TKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDA
SHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVND
ISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAI
KYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLG
LSIAQKIIQLNGGSIKIKSEINKGTTFKIIF
>CNEAMKEG_00062 2-oxoglutarate dehydrogenase E1 component
MTNERKEVSEAPVNFGANLGLMLDLYDDFLQDPSSVPEDLQVLFSTIKNDDSIVPALKST
SSQNSDGTIKRVMRLIDNIRQYGHLKADIYPVNPPKRKHVPKLEIEDFDLDQQTLEGISA
GIVSDHFADIYDNAYEAILRMEKRYKGPIAFEYTHINNNTERGWLKRRIETPYKVTLNNN
EKRALFKQLAYVEGFEKYLHKNFVGAKRFSIEGVDALVPMLQRTITIAAKEGIKNIQIGM
AHRGRLNVLTHVLEKPYEMMISEFMHTDPMKFLPEDGSLQLTAGWTGDVKYHLGGIKTTD
SYGTMQRIALANNPSHLEIVAPVVEGRTRAAQDDTQRAGAPTTDHHKAMPIIIHGDAAYP
GQGINFETMNLGNLKGYSTGGSLHIITNNRIGFTTEPIDARSTTYSTDVAKGYDVPIFHV
NADDVEATIEAIDIAMEFRKEFHKDVVIDLVGYRRFGHNEMDEPSITNPVPYQNIRKHDS
VEYVFGKKLVNEGVISEDEMHSFIEQVQKELRQAHDKINKADKMDNPDMEKPAELALPLQ
ADEQSFTFDHLKEINDALLTYPDGFNILKKLNKVLEKRHEPFNKEDGLVDWAQAEQLAFA
TILQDGTPIRLTGQDSERGTFSHRHAVLHDEQTGETYTPLHHVPDQKATFDIHNSPLSEA
AVVGFEYGYNVENKKSFNIWEAQYGDFANMSQMIFDNFLFSSRSKWGERSGLTLFLPHAY
EGQGPEHSSARLERFLQLAAENNCTVVNLSSSSNYFHLLRAQAASLDSEQMRPLVVMSPK
SLLRNKTVAKPIDEFTSGGFEPILTESYQADKVTKVILATGKMFIDLKEALAKNPDESVL
LVAIERLYPFPEEEIEALLAQLPNLEEVSWVQEEPKNQGAWLYVYPYVKVLVADKYDLSY
HGRIQRAAPAEGDGEIHKLVQNKIIENALKNN
>CNEAMKEG_00063 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MPEVKVPELAESITEGTIAEWLKNVGDSVEKGEAILELETDKVNVEVVSEEAGVLSEQLA
SEGDTVEVGQAIAIIGEGSGNASKENSNDNTPQQNEETNNKKEETTNNSVDKAEVNQAND
DNQQRINATPSARRYARENGVNLAEVSPKTNDVVRKEDIDKKQQAPASTQTTQQAPAKEE
KKYNQYPTKPVIREKMSRRKKTAAKKLLEVSNNTAMLTTFNEVDMTNVMELRKRKKEQFM
KDHDGTKLGFMSFFTKASVAALKKYPEVNAEIDGDDMITKQYYDIGVAVSTDDGLLVPFV
RDCDKKNFAEIEAEIANLAVKAREKKLGLDDMVNGSFTITNGGIFGSMMSTPIINGNQAA
ILGMHSIITRPIAIDQDTIENRPMMYIALSYDHRIIDGKEAVGFLKTIKELIENPEDLLL
ES
>CNEAMKEG_00064 hypothetical protein
MIKISYNIIVKIKIEVAIMCGLRSITLGTTNIEQTKHFMVDILGLNYEELLENSIRFGDA
DISPGTRLQFIQVPSEQLEESHFVGIGLRTPTDSGLEEYAEILSNKDIPFTTVKELNGNK
YFSLEDNNGHIFSIYSNENNYGVGLGMPSFESAVNPLHQVQGLGPVILKVNHVDITGQIL
TNIFGLEVFAEYQPFDNADYHVQVFKVGTGGLGGEIHLMPVETEMTMPEYGAVDQVEFET
KDADFFNQAKSRLDEVEIPYQTLEQDDIESIRITENSGLSFIFTLQK
>CNEAMKEG_00065 hypothetical protein
MLHETWKERTPIKKVEVINTDAKKFTVSDMLTVGKQYDVINETEEYYQIIDNSGLVGGYY
KTYFKEV
